Majd Hakim, MD
Endocrinology, Diabetes & Metabolism · Frederick, MDNPI 1598871378
Payments from drug & device makers
Across 329 payments — averaging $431.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$104K
- AstraZeneca$17K
- AbbVie$17K
- Lilly USA, LLC$361
- Amgen$221
- Amneal Pharmaceuticals LLC$165
- plus $2K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 146 | $104,377 |
| AstraZeneca | 26 | $17,407 |
| AbbVie | 32 | $17,400 |
| Lilly USA, LLC | 17 | $361 |
| Amgen | 13 | $221 |
| Amneal Pharmaceuticals LLC | 10 | $165 |
| Boehringer Ingelheim | 7 | $144 |
| Medtronic | 7 | $144 |
| Corcept Therapeutics | 7 | $128 |
| Radius Health, Inc. | 5 | $109 |
| Xeris Pharmaceuticals, Inc. | 5 | $93 |
| Exelixis Inc. | 1 | $87 |
| Madrigal Pharmaceuticals | 3 | $82 |
| IBSA Pharma Inc. | 4 | $81 |
| Dexcom, Inc. | 4 | $80 |
| Ascendis Pharma Endocrinology Inc | 3 | $78 |
| Insulet Corporation | 3 | $77 |
| Antares Pharma, Inc. | 3 | $69 |
| Abbott | 4 | $66 |
| Tosoh Bioscience, Inc. | 1 | $62 |
| Astellas Pharma US Inc | 2 | $58 |
| GSK | 3 | $55 |
| BETA Bionics, Inc. | 2 | $50 |
| Sanofi-aventis U.S. LLC | 2 | $45 |
| Merck | 2 | $44 |
| Rhythm Pharmaceuticals, Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Chiesi USA, Inc. | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Recordati_rare_diseases_inc. | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $21 |
| Cequr Corporation | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Sequel Med Tech, LLC | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Biotronik NRO, Inc. | 1 | $15 |
| Nevro Corp. | 1 | $13 |
How this compares
$141,805 in reported general payments places this provider in the 90th percentile of 235 endocrinology, diabetes & metabolism providers in Maryland.
See all endocrinology, diabetes & metabolism providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Frederick
- Martin SarkarFrederick$1.1M
- Kayur BhavsarFrederick$7K
- Jean ParkBaltimore$3.7M
- Michael DempseyRockville$2.7M
- Ilias SpanakisBaltimore$2.6M
- Helena RodbardRockville$2.4M
- Daniel GozziSuitland$1.2M
- Romeu AzevedoCamp Springs$1.1M
- Nicholas ArgentoLaurel$1.1M
- Philip LevinBaltimore$702K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.